RA
SNY icon

Reby Advisors’s Sanofi SNY Stock Holding History

Reby Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$35K Buy
+729
New +$36K 0.01% 266

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Reby Advisors's SNY Position: Q4 2020 in Review

Reby Advisors opened a new position in Sanofi (SNY) in Q4 2020: 729 shares worth $35K. The stake represents 0.01% of the portfolio and ranks #266 among its holdings.

602 funds tracked by Wall St. Rank hold SNY as of Q4 2020.

  • Reby Advisors held 729 shares of Sanofi worth $35K as of Q4 2020.
  • Sanofi was a new Reby Advisors position in Q4 2020.
  • Sanofi made up 0.01% of Reby Advisors's portfolio in Q4 2020, its #266 holding.
  • 602 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.